Clinical trial
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
NCT02119819 is registered in ClinicalTrials.gov with OPKO Health, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
- Lead sponsor
- OPKO Health, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- October 31, 2015
- Enrollment
- 420 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.